Table 4b:
Relationships between change in metabolite levels in patients with LLD and change in episodic verbal memory (California Verbal Learning Test): results of linear regression analyses
| Anterior Cingulate Metabolite [/tCr] | β | SE | p | 95% CI |
|---|---|---|---|---|
| GABA | 4.924 | 2.403 | .086 | (−0.954, 10.803) |
| Glu | 2.570 | 1.156 | .068 | (−0.257, 5.398) |
| GSH | −4.833 | 7.340 | .535 | (−22.795, 13.128) |
| NAA | 2.396 | 1.407 | .139 | (−1.046, 5.838) |
| NAAG | −0.918 | 2.295 | .703 | (−6.534, 4.697) |
| mI | 3.583 | 2.328 | .175 | (−2.113, 9.280) |
| Posterior Cingulate Metabolite [/tCr] | β | SE | p | 95% CI |
| GABA | 3.285 | 3.613 | .398 | (−5.557, 12.126) |
| Glu | 4.431 | 2.404 | .115 | (−1.452, 10.314) |
| GSH | 1.063 | 5.288 | .847 | (−11.875, 14.001) |
| NAA | −1.174 | 3.478 | .747 | (−9.684, 7.336) |
| NAAG | 1.372 | 3.217 | .685 | (−6.450, 9.244) |
| mI | −7.187 | 4.340 | .153 | (−17.951, 3.578) |
Total creatine (tCr), γ-aminobutyric acid (GABA), glutamate (Glu), glutathione (GSH), N-acetylaspartate (NAA), N-acetylaspartylglutamate (NAAG) and myo-inositol (mI)